Skip to main content
. 2014 Mar 24;105(5):528–536. doi: 10.1111/cas.12387

Table 2.

Effect of saracatinib on ascites formation and dissemination of 44As3Luc and 58As9 cells

Cell line Treatment Ascites Metastasis
Omentum Mesentery Diaphragm Liver
44As3Luc DMSO 14/16 14/16 16/16 4/16 9/16
Saracatinib 3/18 16/18 15/18 0/18 4/18
58As9 DMSO 8/8 8/8 8/8 8/8 6/8
Saracatinib 3/7 7/7 7/7 5/7 5/7

Number of mice bearing ascites or tumors at the indicated site per total number of mice bearing tumors.